Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 17, 2018Frontiers in NeuroscienceOpen Access

Sphingolipid Metabolism: A New Therapeutic Opportunity for Brain Degenerative Disorders

View Full Paper
Ask AI
Bookmark
Share

Authors

APAlba Di PardoIstituto Neurologico MediterraneoVMVittorio MaglioneIstituto Neurologico Mediterraneo

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Pardo et al. (2018) studied this question.

synapsesocial.com/papers/6a90537efecd36257390a88dhttps://doi.org/10.3389/fnins.2018.00249
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Emerging Role of Sphingosine-1-phosphate in Inflammation, Cancer, and Lymphangiogenesis2013 · 70 citations
  2. 2Sphingosine‐1‐phosphate produced by sphingosine kinase 2 in mitochondria interacts with prohibitin 2 to regulate complex IV assembly and respiration2010 · 369 citations
  3. 3Sphingolipids: membrane microdomains in brain development, function and neurological diseases2017 · 322 citations